Jessica Pittman, M.D., M.P.H.

Profile picture
Medical Director, Pulmonary Function Laboratory, St. Louis Children's Hospital
Co-Director, Pediatric, Therapeutics Development Center
Researcher, Patient Oriented Research Unit
Associate Professor of Pediatrics, Allergy and Pulmonary Medicine
School of MedicineAllergy and Pulmonary MedicinePediatric Residency

phone: (314) 454-2694

Clinical Interests

Dr. Pittman graduated from Oberlin College (Oberlin, OH) in 1998, and earned her M.D. from Washington University in St. Louis School of Medicine (WUSM, St. Louis, MO) in 2004. She received her training in pediatrics at Seattle Children's Hospital (University of Washington Pediatrics Residency, Seattle, WA) before moving to the University of North Carolina at Chapel Hill (Chapel Hill, NC) for her fellowship in Pediatric Pulmonology, where she also received a Master's in Public Health in Epidemiology. Dr. Pittman remained on faculty at the University of North Carolina as an Assistant Professor and served as Director of the UNC Infant and Preschool Pulmonary Function Laboratory before joining the Division of Allergy and Pulmonary Medicine at Washington University in St. Louis School of Medicine in 2014, where she is now an Associate Professor. Her roles at Washington University School of Medicine include Co-Director of the WUSM/SLCH Cystic Fibrosis Therapeutics Development Center, Associate Program Director for Diversity and Inclusion for the WUSM/SLCH Pediatric Residency Program, Coach for the WUSM Gateway Curriculum, and DEI Faculty Leader through the WUSM Office of Diversity, Equity, and Inclusion. She previously served as Medical Director of the St. Louis Children's Hospital (SLCH) Pulmonary Function Laboratory from 2014 - 2021.

Dr. Pittman's clinical interests include early childhood lung disease, cystic fibrosis, primary ciliary dyskinesia, and asthma, as well as pulmonary function testing, including multiple breath washout (MBW) testing. Dr. Pittman's primary research interest is improving the diagnosis and detection of early lung disease in infancy and early childhood through the use of novel outcome measures. She is a past recipient of the Cystic Fibrosis Foundation Leroy Matthews Physician/Scientist Award, a WUSM Omics of Inflammatory Airways Disease K12 Award, a WUSM Children's Discovery Institute Award (2015 - 2018) and a Cystic Fibrosis Foundation Clinical Research Scholars Program Award (2016 - 2019). She served as the Director of the Cystic Fibrosis Foundation Therapeutics Development Network Center for Infant and Preschool Pulmonary Function Testing from 2019 - 2020, and was associate director from 2011 - 2018, focusing on improving the standardization of multiple breath washout testing and collecting normative data for MBW measures. Dr. Pittman has participated in research studies involving children with cystic fibrosis, primary ciliary dyskinesia, and asthma/wheeze, including several multi-center NIH studies. She is currently involved with several longitudinal studies of children with CF in partnership with the CFF Therapeutics Development Network.

Dr. Pittman assumed the role of Associate Program Director for Diversity and Inclusion for the WUSM/SLCH Pediatric Residency Program in 2018, and has broadened her role in education and diversity/equity/inclusion work since. She co-founded the SLCH/WUSM Taskforce on Teamwork and Cultural Competency (T2C2), an inter-professional group dedicated to improving patient and staff experiences throughout Children's Hospital, with a focus on issues related to teamwork and diversity/inclusion. She then began working with the WUSM Office of Diversity, Equity and Inclusion under Dr. Sherree Wilson, and formally joined the office in 2020 as a DEI Faculty Leader. In the WUSM ODEI Dr. Pittman serves as co-lead for the WUSM ODEI Understanding Systemic Racism Curriculum, a comprehensive, campus-wide curriculum in anti-racism, and lead for the DEI Liaison Group. Dr. Pittman became a medical student coach for the new WUSM Gateway curriculum in 2020. She now serves on several committees related to diversity/equity/inclusion work and education across WUSM and SLCH. She teaches curricula related to implicit bias, structural racism, anti-racist practice, and cultural humility across campus for medical providers at all levels of training. Dr. Pittman now also serves as an Assistant Subcommittee Chair for the WUSM Committee on Admissions.


  • BA, High Honors in Biology awarded June, 1998, Oberlin College1998
  • MD, Washington University School of Medicine2004
  • MPH, University of North Carolina at Chapel Hill School of Public Health2009


  • Pediatric Intern, University of Washington School of Medicine/ Seattle Children's Hospital & Regional Medical Center2004 - 2005
  • Pediatric Resident, University of Washington School of Medicine/ Seattle Children's Hospital & Regional Medical Center2005 - 2007
  • Associate Chief Pediatric Resident, University of Washington School of Medicine/ Seattle Children's Hospital & Regional Medical Center2007 - 2007
  • Fellow, Pediatric Pulmonology, University of North Carolina at Chapel Hill Hospitals2007 - 2011
  • Research Fellow, Division of Pediatric Respirology, Toronto Hospital for Sick Children2012 - 2012

Licensure and Board Certification

  • American Board of Pediatrics, General Pediatrics
  • American Board of Pediatrics, Pediatric Pulmonology
  • MO, Medical License, State of Missouri
  • NC, Medical License, State of North Carolina

Honors and Awards

  • Howard Hughes Summer Internship at the National Institutes of Health1995
  • Presidential Scholar, Oberlin College1995 - 1998
  • Project Excellence Minority Scholarship, Oberlin College1995 - 1998
  • Science Scholars Scholarship, Oberlin College1995 - 1998
  • National Institutes of Health Summer Intramural Research Training Award1996
  • Howard Hughes Summer Internship, Oberlin College1997
  • High Honors in Biology, Oberlin College1998
  • Sigma Xi, Oberlin College1998
  • Phi Beta Kappa, Oberlin College1998
  • Distinguished Alumni Scholarship, Washington University School of Medicine2000 - 2004
  • Olin Fellowship for Women, Washington University School of Medicine2000 - 2004
  • George F. Gill Prize in Pediatrics (for superior scholarship in pediatrics), Washington University School of Medicine2004
  • Abraham Bergman Prize, Harborview Medical Center, Seattle, WA, Department of Pediatrics. Given to the resident who most effectively acts to advance the well-being of children treated while providing exemplary care to pediatric patients and families.2006
  • Minority Trainee Travel Award, American Thoracic Society2008
  • Pulmonary/Critical Care Training Program Travel Scholarship, American Thoracic Society2009
  • Tunnessen Award for Clinical Science Research, Evening of Scholarship, University of North Carolina at Chapel Hill School of Medicine, Department of Pediatrics2009
  • Tunnessen Award for Clinical Science Research, Evening of Scholarship, University of North Carolina at Chapel Hill School of Medicine, Department of Pediatrics2010
  • 1st Prize, Clinical Fellows Abstract Award, University of North Carolina/Duke University Visiting Pulmonary Scholar Symposium2011
  • Assembly on Pediatrics Scientific Abstract Award, American Thoracic Society2011
  • Assembly on Pediatrics Travel Award, American Thoracic Society2011
  • WUSM Pediatrics Clerkship Faculty Teaching Award (Block 3)2021
  • Washington University School of Medicine Distinguished Service Teaching Award: Medicine & Society (Class of 2022)2022

Recent Publications view all (32)

Publication Co-Authors

  1. Impact of azithromycin on serum inflammatory markers in children with cystic fibrosis and new Pseudomonas J Cyst Fibros. 2022;epub ahead of print. PMID:35260354 
  2. Clinical Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor in People with Cystic Fibrosis: A Clinical Trial Am J Respir Crit Care Med. 2022;205(5):529-539. PMID:34784492 
  3. Rates of adverse and serious adverse events in children with cystic fibrosis. J Cyst Fibros. 2021;20(6):972-977. PMID:33745860 
  4. PROMISE: Working with the CF community to understand emerging clinical and research needs for those treated with highly effective CFTR modulator therapy. J Cyst Fibros. 2021;20(2):205-212. PMID:33619012 
  5. Comparison of Multiple Breath Washout and Spirometry in Children with Primary Ciliary Dyskinesia and Cystic Fibrosis and Healthy Controls Ann Am Thorac Soc. 2020;17(9):1085 - 1093. doi:10.1513/AnnalsATS.201905-375OC  PMCID:PMC7462330  PMID:32603187 
  6. Primary Ciliary Dyskinesia: Longitudinal Study of Lung Disease by Ultrastructure Defect and Genotype. Am J Respir Crit Care Med. 2019;199(2):190-198. PMCID:PMC6353004  PMID:30067075 
  7. Diagnosis of Primary Ciliary Dyskinesia. An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2018;197(12):e24-e39. PMCID:PMC6006411  PMID:29905515 
  8. Preschool Multiple-Breath Washout Testing. An Official American Thoracic Society Technical Statement. Am J Respir Crit Care Med. 2018;197(5):e1-e19. PMID:29493315 
  9. ATS Core Curriculum 2017: Part II. Pediatric Pulmonary Medicine. Ann Am Thorac Soc. 2017;14(Supplement_2):S165-S181. PMCID:PMC5802517  PMID:28857623 
  10. Association of Antibiotics, Airway Microbiome and Inflammation in Infants with Cystic Fibrosis. Ann Am Thorac Soc. 2017. PMID:28708417 
  11. Early childhood lung function is a stronger predictor of adolescent lung function in cystic fibrosis than early Pseudomonas aeruginosa infection. PLoS One. 2017;12(5):e0177215. PMCID:PMC5432103  PMID:28505188 
  12. Elementary, My Dear Watson! The Accumulating Evidence for the Lung Clearance Index in Monitoring Early Cystic Fibrosis Lung Disease. Am J Respir Crit Care Med. 2017;195(9):1131-1132. PMID:28459345 
  13. Diagnostic Evaluation of Infants with Recurrent or Persistent Wheezing. Ann Am Thorac Soc. 2016;13(11):2057-2059. PMID:27831796 
  14. Pediatric Pulmonary Hypertension. Ann Am Thorac Soc. 2016;13(6):967-9. PMID:27295157 
  15. Clinical Features and Associated Likelihood of Primary Ciliary Dyskinesia in Children and Adolescents. Ann Am Thorac Soc. 2016. doi:10.1513/AnnalsATS.201511-748OC  PMID:27070726 
  16. Assessment and Detection of Early Lung Disease in Cystic Fibrosis Pediatr Allergy Immunol. 2015;28(4):212-219. 
  17. Decline in Forced Expiratory Volume in 1 Second in Cystic Fibrosis--Watch the Pendulum Swing. J Pediatr. 2015. doi:10.1016/j.jpeds.2015.10.033  PMID:26547404 
  18. Multiple-Breath Washout as a Lung Function Test in Cystic Fibrosis. A Cystic Fibrosis Foundation Workshop Report. Ann Am Thorac Soc. 2015;12(6):932-9. doi:10.1513/AnnalsATS.201501-021FR  PMID:26075554 
  19. The Evolution of Cystic Fibrosis Care. Chest. 2015. doi:10.1378/chest.14-1997  PMID:25764168 
  20. Clinical features of childhood primary ciliary dyskinesia by genotype and ultrastructural phenotype. Am J Respir Crit Care Med. 2014. doi:10.1164/rccm.201409-1672OC  PMID:25493340 
  21. Cystic fibrosis: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases. Ann Am Thorac Soc. 2014;11(Suppl 3):S161-8. doi:10.1513/AnnalsATS.201312-444LD  PMID:24754825 
  22. Zebrafish Ciliopathy Screen Plus Human Mutational Analysis Identifies C21orf59 and CCDC65 Defects as Causing Primary Ciliary Dyskinesia. Am J Hum Genet. 2013;93(4):672-86. doi:10.1016/j.ajhg.2013.08.015  PMCID:PMC3791264  PMID:24094744 
  23. ZMYND10 is mutated in primary ciliary dyskinesia and interacts with LRRC6. Am J Hum Genet. 2013;93(2):336-45. doi:10.1016/j.ajhg.2013.06.007  PMCID:PMC3738827  PMID:23891469 
  24. Variability of a closed, rebreathing setup for multiple breath wash-out testing in children. Pediatr Pulmonol. 2012;47(12):1242-50. doi:10.1002/ppul.22531  PMID:22467329 
  25. Improvement in pulmonary function following antibiotics in infants with cystic fibrosis. Pediatr Pulmonol. 2012;47(5):441-6. doi:10.1002/ppul.21575  PMID:22009796 
  26. Spirometry in biracial children: how adequate are race-based reference equations? Arch Pediatr Adolesc Med. 2011;165(6):573-4. doi:10.1001/archpediatrics.2011.76  PMID:21646594 
  27. Appropriate pediatric spirometric reference equations and interpretation. Pediatric Allergy, Immunology, and Pulmonology. 2011;24(2):63-68. 
  28. Age of Pseudomonas aeruginosa acquisition and subsequent severity of cystic fibrosis lung disease. Pediatr Pulmonol. 2010. doi:10.1002/ppul.21397  PMID:21194167 
  29. Clinical and genetic aspects of primary ciliary dyskinesia/Kartagener syndrome. Genet Med. 2009;11(7):473-87. doi:10.1097/GIM.0b013e3181a53562  PMCID:PMC3739704  PMID:19606528 
  30. Early lung disease in young children with primary ciliary dyskinesia. Pediatr Pulmonol. 2008;43(5):514-6. doi:10.1002/ppul.20792  PMID:18383332 
  31. Quantifying pulmonary inflammation in cystic fibrosis with positron emission tomography. Am J Respir Crit Care Med. 2006;173(12):1363-9. doi:10.1164/rccm.200506-934OC  PMCID:PMC2662975  PMID:16543553 
  32. The identification of secreted heat shock 60 -like protein from rat glial cells and a human neuroblastoma cell line. Neurosci Lett. 1998;250(1):37-40. PMID:9696060 
Last updated: 10/31/2022
© 2022 by Washington University in St. Louis
One Brookings Drive, St. Louis, MO 63130